Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: University of Michigan Rogel Cancer Center
Condition: Lymphoma, T-Cell
NCT02158975
Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.